Drugs -- Law and legislation -- United States
Resource Information
The concept Drugs -- Law and legislation -- United States represents the subject, aboutness, idea or notion of resources found in University of Missouri-St. Louis Libraries.
The Resource
Drugs -- Law and legislation -- United States
Resource Information
The concept Drugs -- Law and legislation -- United States represents the subject, aboutness, idea or notion of resources found in University of Missouri-St. Louis Libraries.
- Label
- Drugs -- Law and legislation -- United States
159 Items that share the Concept Drugs -- Law and legislation -- United States
Context
Context of Drugs -- Law and legislation -- United StatesSubject of
No resources found
No enriched resources found
- "Medical" marijuana, federal drug law, and the constitution's supremacy clause : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Seventh Congress, first session, March 27, 2001
- "Medical" marijuana, federal drug law, and the constitution's supremacy clause : hearing before the Subcommittee on Criminal Justice, Drug Policy, and Human Resources of the Committee on Government Reform, House of Representatives, One Hundred Seventh Congress, first session, March 27, 2001
- A compilation of third party program litigation
- A handbook on the 1970 Federal drug act : shifting the perspective,
- A handbook on the 1970 Federal drug act ; : shifting the perspective
- A handbook on the 1970 Federal drug act; : shifting the perspective,
- A system overwhelmed : the avalanche of imported, counterfeit, and unapproved drugs into the U.S. : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, first session, June 24, 2003
- American chamber of horrors : the truth about food and drugs
- American chamber of horrors : the truth about food and drugs
- An Act to Amend the Controlled Substances Import and Export Act to Place Limitations on Controlled Substances Brought into the United States
- An Act to Amend the Controlled Substances Import and Export Act to Provide Authority for the Attorney General to Authorize the Export of Controlled Substances from the United States to Another Country for Subsequent Export from that Country to a Second Country, if Certain Conditions and Safeguards are Satisfied
- An Act to Amend the Federal Food, Drug, and Cosmetic Act to Authorize Human Drug Application, Prescription Drug Establishment, and Prescription Drug Product Fees and for Other Purposes
- An Act to Amend the Federal Food, Drug, and Cosmetic Act to Clarify the Application of the Act with Respect to Alternate Uses of New Animal Drugs and New Drugs Intended for Human Use, and for Other Purposes
- An Act to Amend the Federal Food, Drug, and Cosmetic Act to Coordinate Federal and State Regulation of Wholesale Drug Distribution, and for Other Purposes
- An Act to Extend the Temporary Scheduling Order for Fentanyl-Related Substances, and for Other Purposes
- An Act to Extend the Temporary Scheduling Order for Fentanyl-Related Substances, and for Other Purposes
- An Act to Facilitate the Creation of Methamphetamine Precursor Electronic Logbook Systems, and for Other Purposes
- An Act to Prevent the Illegal Manufacturing and Use of Methamphetamine
- Anticompetitive abuse of the Orphan Drug Act : invitation to high prices : hearing before the Subcommittee on Antitrust, Monopolies, and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, second session, on S. 2060, a bill to revise the orphan drug provisions of the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act, and for other purposes, January 21, 1992
- Basic food and drug law
- Best Pharmaceuticals for Children Act
- Biodefense and Pandemic Vaccine and Drug Development Act of 2006 : report (to accompany H.R. 5533) (including cost estimate of the Congressional Budget Office)
- By-laws and operating procedures
- Canadian prescription drug importation : is there a safety issue? : hearing before the Subcommittee on Human Rights and Wellness of the Committee on Government Reform, House of Representatives, One Hundred Eighth Congress, first session, June 12 2003
- Coast Guard drug interdiction and Cutter procurement : background and resource issues
- Compilation of laws enforced by the U.S. Food and Drug Administration and related statutes
- Compilation of selected acts within the jurisdiction of the Committee on Energy and Commerce : food, drug, and related law : including Federal Food, Drug, and Cosmetic Act, Controlled Substances Act ...
- Compilation of selected acts within the jurisdiction of the Committee on Energy and Commerce : including Federal Food, Drug, and Cosmetic Act, Controlled Substances Act ..., Food, drug, and related law
- Comprehensive Methamphetamine Control Act of 1996 : hearing before the Subcommittee on Crime of the Committee on the Judiciary, House of Representatives, One Hundred Fourth Congress, second session, on H.R. 3852 ... September 5, 1996
- Controlled Substances Act : as amended to July 1, 1991 : also includes chapter 53 of Title 31, United States Code, relating to money and finance
- Controlled Substances Act as amended to February 15, 1996 : also includes chapter 53 of Title 31, United States Code, relating to monetary Instruments Transactions and Title 46, App. chapter 38: Maritime Drug Law Enforcement
- Controlled Substances Export Reform Act of 2005 : report (to accompany H.R. 184) (including cost estimate of the Congressional Budget Office)
- Controlled Substances Export Reform Act of 2005 : report (to accompany H.R. 184) (including cost estimate of the Congressional Budget Office)
- Controlled Substances Trafficking Prohibition Act : report (to accompany H.R. 3633) (including cost estimate of the Congressional Budget Office)
- Controlled Substances Trafficking Prohibition Act and Correction Officers Health and Safety Act of 1997 : hearing before the Subcommittee on Crime of the Committee on the Judiciary, House of Representatives, One Hundred Fifth Congress, second session, on H.R. 3633 and H.R. 2070, March 26, 1998
- Controlled substance quotas
- Coordinated Response through Interagency Strategy and Information Sharing Act : report (to accompany H.R. 5925) (including cost estimate of the Congressional Budget Office)
- Counterfeit Drug Penalty Enhancement Act of 2012 : report (to accompany H.R. 3668) (including cost estimate of the Congressional Budget Office)
- Creating Hope Reauthorization Act : report (to accompany H.R. 4439)
- Discussion draft of the Food and Drug Administration Globalization Act legislation : drug safety : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, May 1, 2008
- Drug Trafficking Vessel Interdiction Act of 2008
- Drugs : many consumers at risk due to poor labeling, lax federal regulation, and a review process that present special problems for the elderly : joint hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business and the Subcommittee on Housing and Consumer Interests of the Select Committee on Aging, House of Representatives, One Hundred Second Congress, second session, Washington, DC, April 28, 1992
- Drugs and justice : seeking a consistent, coherent, comprehensive view
- Drugs and justice : seeking a consistent, coherent, comprehensive view
- Drugs and the public
- Drugs in American life
- Drugs, addiction, and the law : policy, politics, and public health
- Drugs, crime, and violence : from trafficking to treatment
- Drugs, dignity, and death : physician-assisted suicide? : hearing before the Committee on the Judiciary, United States Senate, One Hundred Fifth Congress, second session, on S. 2151 ... July 31, 1998
- Ensuring Patient Access and Effective Drug Enforcement Act of 2014 : report (to accompany H.R. 4709) (including cost estimate of the Congressional Budget Office)
- Ensuring Patient Access and Effective Drug Enforcement Act of 2015 : report (to accompany H.R. 471) (including cost estimate of the Congressional Budget Office)
- Ensuring Patient Access and Effective Drug Enforcement Act of 2016
- EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY)
- EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY)
- Examining FDA's Prescription Drug User Fee program : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017
- Examining FDA's generic drug and biosimilar user fee programs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 2, 2017
- Examining legislative proposals to combat our nation's drug abuse crisis : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, first session, October 8 & 20, 2015
- Examining prescription drug importation : a review of a proposal to allow third parties to reimport prescription drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, July 25, 2002
- Examining prescription drug importation : a review of a proposal to allow third parties to reimport prescription drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, July 25, 2002
- FDA Amendments Act of 2007 (P.L. 110-85)
- FDA in the twenty-first century : the challenges of regulating drugs and new technologies
- FDA regulation of follow-on biologics
- FDA regulations : sustained management attention needed to improve timely issuance : statement of Mark V. Nadel, Associate Director, National and Public Health Issues, Human Resources Division, before the Subcommittee on Health and the Environment, Committee on Energy and Commerce, House of Representatives
- FDA review times : statement of Mary R. Hamilton, Director of Program Evaluation in Human Services Areas, Program Evaluation and Methodology Division, before the Subcommittee on Health and Environment, Committee on Commerce, House of Representatives
- FDA user fees : current measures not sufficient for evaluating effect on public health : report to the Chairman, Human Resources and Intergovernmental Relations Subcommittee, Committee on Government Operations, House of Representatives
- Fairness in Orphan Drug Exclusivity Act : report (to accompany H.R. 4712)
- Federal Food, Drug, and Cosmetic Act
- Federal Food, Drug, and Cosmetic Act, as amended
- Federal drug enforcement : history, policies, trends
- Federal drug enforcement : history, policies, trends
- Federal drug offenses : departures from sentencing guidelines and mandatory minimum sentences, fiscal years 1999-2001
- Federal food, drug, and cosmetic act : a statement of its legislative record
- Filthy food, dubious drugs, and defective devices : the legacy of FDA's antiquated statute : a staff report
- Food and Drug Administration Modernization Act of 1997 : FDA plan for statutory compliance
- Food and Drug Administration Reform Act of 2012 : report (to accompany H.R. 5651) (including cost estimate of the Congressional Budget Office)
- Food and drug legislation in the New Deal
- Food, Drug, Cosmetic, and Device Enforcement Authorities Act : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, second session, on S. 2135 to amend the Federal Food, Drug, and Cosmetic Act to enhance the enforcement authority of the Food and Drug Administration, and for other purposes, May 19, 1992
- Food, Drug, Cosmetic, and Device Safety Amendments of 1992 : report together with dissenting views (to accompany H.R. 3642) (including cost estimate of the Congressional Budget Office)
- Food, drug, cosmetic, and device enforcement amendments : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2597, a bill to amend the Federal Food, Drug, and Cosmetic Act to enhance the enforcement authority of the Food and Drug Administration, July 17, 1991
- Generic drug enforcement : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, on H.R. 2454 ... June 26, 1991
- Handbook of federal drug law
- Heroin trafficking in the United States
- How FDA approves drugs and regulates their safety and effectiveness
- Improving predictability and transparency in DEA and FDA regulation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014
- International cooperative agreements manual
- Is impossibility preemption impossible? : federal drug law and preemption of state tort claims
- Law for the pharmacy student
- Legal authorities under the Controlled Substances Act to combat the opioid crisis
- Lethal Drug Abuse Prevention Act : report together with additional and minority views (to accompany S. 2151)
- Lethal Drug Abuse Prevention Act of 1998 : hearing before the Subcommittee on the Constitution of the Committee on the Judiciary, House of Representatives, One Hundred Fifth Congress, second session, on H.R. 4006, July 14, 1998
- Lethal Drug Abuse Prevention Act of 1998 : report together with dissenting views (to accompany H.R. 4006) (including cost estimate of the Congressional Budget Office)
- Lower Drug Costs Now Act of 2019 : report of the Committee on Energy and Commerce
- Medical product innovation and regulation : benefits and risks
- Medical product innovation and regulation : benefits vs. risks
- Medical product regulation : drugs, biologics, and devices
- Methamphetamine Epidemic Elimination Act : hearing before the Subcommittee on Crime, Terrorism, and Homeland Security of the Committee on the Judiciary, House of Representatives, One Hundred Ninth Congress, first session, on H.R. 3889, September 27, 2005
- Methamphetamine and Club Drug Anti-Proliferation Act of 2000 : report (to accompany H.R. 2987)
- Mid-session field hearings : hearings before the Committee on the Budget, United States Senate, One Hundred Seventh Congress, second session
- Modernizing FDA's regulation of over-the-counter drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. September 13, 2017
- More information for better patient care : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, second session, on S. 1477, to amend the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to improve the regulation of food, drugs, devices, and biological products, February 22, 1996
- Opioid treatment programs and related federal regulations
- Orphan Drug Act Amendments of 1994 : report together with dissenting views (to accompany H.R. 4865) (including cost estimate of the Congressional Budget Office)
- Orphan drug reauthorization : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session on H.R. 4160, a bill to amend the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act to revise the provisions of such acts relating to orphan drugs, June 16, 1994
- Pain Relief Promotion Act : hearing before the Committee on the Judiciary, United States Senate, One Hundred Sixth Congress, second session on H.R. 2260, April 25, 2000
- Pain Relief Promotion Act : hearing before the Committee on the Judiciary, United States Senate, One Hundred Sixth Congress, second session on H.R. 2260, April 25, 2000
- Pain Relief Promotion Act of 1999 : hearing before the Subcommittee on the Constitution of the Committee on the Judiciary, House of Representatives, One Hundred Sixth Congress, first session, on H.R. 2260, June 24, 1999
- Pain Relief Promotion Act of 1999 : report together with dissenting views (to accompany H.R. 2260) (including cost estimate of the Congressional Budget Office)
- Pain management and improving end-of-life care : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, first session, on ... S. 1272 ... and S. 941 ... October 13, 1999
- Pay to delay : are patent settlements that delay generic drug market entry anticompetitive? : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, June 3, 2009
- Pediatric Research Equity Act of 2003
- Pediatric Research Equity Act of 2003 : report together with additional views (to accompany S. 650)
- Pharmaceutical patent issues : interpreting GATT : hearings before the Committee on the Judiciary, United States Senate, One Hundred Fourth Congress, second session ... S. 1277, a bill to provide equitable relief for the generic drug industry, and for other purposes, February 27, and March 5, 1996
- Pharmacopolitics : drug regulation in the United States and Germany
- Pharmacopolitics : drug regulation in the United States and Germany
- Pills, profits, and politics
- Prescription Drug User Fee Act (PDUFA : 2012 reauthorization as PDUFA V
- Prescription Drug User Fee Act (PDUFA : 2017 reauthorization as PDUFA VI
- Prescription Drug User Fee Act of 1992 : report (to accompany H.R. 5952) (including cost estimate of the Congressional Budget Office)
- Prescription Drug User Fee Reauthorization and Drug Regulatory Modernization Act of 1997 : report, together with additional views (to accompany H.R. 1411) (including cost estimate of the Congressional Budget Office)
- Prescription drugs : strategic framework would promote accountability and enhance efforts to enforce the prohibitions on personal importation : report to congressional requesters
- Preserve Access to Affordable Generics Act : report together with minority views (to accompany S. 369) (including cost estimate of the Congressional Budget Office)
- Protecting Patient Access to Emergency Medications Act of 2016 : report (to accompany H.R. 4365)
- Providing for consideration of H.R. 2427, Pharmaceutical Market Access Act of 2003 : report (to accompany H. Res. 335)
- Providing for the consideration of H.R. 2260, Pain Relief Promotion Act of 1999 : report (to accompany H. Res. 339)
- Providing for the consideration of H.R. 4006, Lethal Drug Abuse Prevention Act of 1998 : report (to accompany H. Res. 535)
- Pure food : securing the Federal Food and Drugs Act of 1906
- Pure food : securing the Federal Food and Drugs Act of 1906
- Reauthorization of PDUFA : what it means for jobs, innovation, and patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 1, 2012
- Reforming Federal drug regulation : a round table held on February 23, 1976, and sponsored by the Center for Health Policy Research of the American Enterprise Institute for Public Policy Research, Washington, D.C.
- Regulation of over-the-counter (OTC) drugs
- Regulation of pharmaceutical innovation : the 1962 amendments
- Regulatory exclusivity reform in the 115th Congress
- Remedies and rackets : the truth about patent medicines today
- Report on FDA plan for statutory compliance
- Revitalizing new product development from clinical trials through FDA review : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Fourth Congress, second session, on S. 1477 ... February 21, 1996
- S. 334 : an approach to drug importation : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining S. 334, to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, April 19, 2005
- Safe Doses Act, the Counterfeit Drug Penalty Enhancement Act of 2011, and the Foreign Counterfeit Prevention Act : hearing before the Subcommittee on Crime, Terrorism, and Homeland Security of the Committee on the Judiciary, House of Representatives, One Hundred Twelfth Congress, second session, on H.R. 4223, H.R. 3668, and H.R. 4216, March 28, 2012
- Safe Doses Act, the Counterfeit Drug Penalty Enhancement Act of 2011, and the Foreign Counterfeit Prevention Act : hearing before the Subcommittee on Crime, Terrorism, and Homeland Security of the Committee on the Judiciary, House of Representatives, One Hundred Twelfth Congress, second session, on H.R. 4223, H.R. 3668, and H.R. 4216, March 28, 2012
- Safe Drug Disposal Act of 2010 : report (to accompany H.R. 5809) (including cost estimate of the Congressional Budget Office)
- Safeguarding Therapeutics Act : report (to accompany H.R. 5663)
- Scheduling of fentanyl analogues : the new legal landscape
- Secure and Responsible Drug Disposal Act of 2010
- Specialty drugs : background and policy concerns
- State Rewards Program Update and Technical Corrections Act of 2012 : report (to accompany S. 2318)
- Stop the Importation and Trafficking of Synthetic Analogues Act of 2017 : report together with dissenting views (to accompany H.R. 2851) (including cost estimate of the Congressional Budget Office)
- Taking your medicine : drug regulation in the United States
- The Food and Drugs Act as it relates to drugs examined and explained in connection with the rules and regulations for its enforcement
- The Pain Relief Promotion Act : report together with minority views (to accompany H.R. 2260)
- The Proposed Drug Quality and Security Act (H.R. 3204
- The U.S. food and drug law : how it came, how it works
- The law of biologic medicine : hearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, second session, June 23, 2004
- The war on drugs
- To apply counterinsurgency tactics under a coordinated and targeted strategy to combat the terrorist insurgency in Mexico waged by transnational criminal organizations, and for other purposes; and to withhold twenty percent of United States assessed and voluntary contributions to the Organization of American States (OAS) for every Permanent Council meeting that takes place where Article 20 of the Inter-American Charter is not invoked with regard to Venezuela's recent constitutional reforms, and for other purposes : markup before the Subcommittee on the Western Hemisphere of the Committee on Foreign Affairs, House of Representatives, One Hundred Twelfth Congress, first session, on H.R. 3401 and H.R. 2542, December 15, 2011
- USA PATRIOT Improvement and Reauthorization Act of 2005
- Update, all eyes on Allergan : drug company's unprecedented move raises questions for patent and drug law, Part I
- Utilization of the IRS to combat narcotics trafficking : a question of policy
- VA Prescription Data Accountability Act 2017 : report (to accompany H.R. 1545) (including cost estimate of the Congressional Budget Office)
- Wheeler-Lea act : a statement of its legislative record
- [The interim report by Commission on Combating Drug Addiction and the Opioid Crisis] : [draft]
Embed
Settings
Select options that apply then copy and paste the RDF/HTML data fragment to include in your application
Embed this data in a secure (HTTPS) page:
Layout options:
Include data citation:
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.umsl.edu/resource/kSnHyi50WJ8/" typeof="CategoryCode http://bibfra.me/vocab/lite/Concept"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.umsl.edu/resource/kSnHyi50WJ8/">Drugs -- Law and legislation -- United States</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.umsl.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.umsl.edu/">University of Missouri-St. Louis Libraries</a></span></span></span></span></div>
Note: Adjust the width and height settings defined in the RDF/HTML code fragment to best match your requirements
Preview
Cite Data - Experimental
Data Citation of the Concept Drugs -- Law and legislation -- United States
Copy and paste the following RDF/HTML data fragment to cite this resource
<div class="citation" vocab="http://schema.org/"><i class="fa fa-external-link-square fa-fw"></i> Data from <span resource="http://link.umsl.edu/resource/kSnHyi50WJ8/" typeof="CategoryCode http://bibfra.me/vocab/lite/Concept"><span property="name http://bibfra.me/vocab/lite/label"><a href="http://link.umsl.edu/resource/kSnHyi50WJ8/">Drugs -- Law and legislation -- United States</a></span> - <span property="potentialAction" typeOf="OrganizeAction"><span property="agent" typeof="LibrarySystem http://library.link/vocab/LibrarySystem" resource="http://link.umsl.edu/"><span property="name http://bibfra.me/vocab/lite/label"><a property="url" href="http://link.umsl.edu/">University of Missouri-St. Louis Libraries</a></span></span></span></span></div>
